Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency

By afschroeder • August 8, 2025

Nasseri Moghaddam Z, Reinhardt EK, Thurm A, Potter BK, Smith M, Graham C, Tiller BH, Baker SA, Bilder DA, Bogar R, Britz J, Cafferty R, Coller DP, DeGrauw TJ, Hall V, Lipshutz GS, Longo N, Mercimek-Andrews S, Miller JS, Pasquali M, Salomons GS, Schulze A, Wheaton CP, Williams KF, Young SP, Li J, Balog S, Selucky T, Stöckler-Ipsiroglu S, Wallis H. Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency. Orphanet J Rare Dis. 2025 Aug 7;20(1):408. doi: 10.1186/s13023-025-03900-3. PMID: 40775643.

Tags: Core outcome set (COS), Creatine transporter deficiency, Endocrinology, Guanidinoacetate methyltransferase deficiency, Patient focused drug development. Patient-centered research, Publications, rare disease

A Spanish-language educational intervention to enhance diabetes outcomes among existing continuous glucose monitor users in a federally qualified health care center

Tavares M, Khoshbin K, Solorzano W, Scarlett L, Santana C, Lopez R, Villanueva GP, Escobar B, Mangual KS, Pavlish C, Bush NJ, Moin T, Everett[...]

Enhancing mental and physical health of women through engagement and retention (EMPOWER) 3.0 QUERI: study protocol for a cluster-randomized hybrid type 3 implementation-effectiveness trial

Hamilton AB, Farmer MM, Bean-Mayberry B, Moin T, Lang A, Adams L, Chanfreau C, Fenwick K, Canelo I, Oberman R, Finley EP; EMPOWER 3.0 QUERI[...]

Mitochondrial calcium regulates lipid metabolism by modulating tethering of mitochondria to lipid droplets

Acin-Perez R, Assali EA, Veliova M, Ngo J, Brownstein AJ, Villalobos F, Petcherski A, Hernansanz-Agustin P, Kim-Vasquez D, Xu S, Tamboline M, Silva RM, Upcher[...]